Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what estimate she has made on the proportion of funding for clinical brain tumour research spent in each region of the UK in the latest period for which data is available.
The Department funds research through the National Institute for Health and Care Research (NIHR). NIHR programme spend on brain tumour research for the financial year 2022/23 was £2,028,646, distributed regionally to research organisations as set out in Table 1. It should be noted that NIHR programme funding is typically awarded to a lead researcher at a research organisation who then coordinates the delivery of the research study at a national level as required.
The NIHR also devotes significant resources to supporting patients, the public and health and care organisations across England to participate in high-quality research, thereby advancing knowledge and improving care. However, NIHR does not hold information by region on the delivery of individual research studies.
Table 1: Region of lead institution to which NIHR research programme awards were made
Region | Spend 22_23 |
Merseyside | 23.4% |
Greater London | 18.0% |
Cambridgeshire | 12.1% |
Oxfordshire | 10.8% |
South Yorkshire | 9.8% |
West Yorkshire | 8.9% |
Midlothian | 8.1% |
Nottinghamshire | 4.4% |
West Midland | 2.2% |
Somerset | 1.4% |
North Yorkshire | 1.0% |
Total | 100.0% |